Companion SuiteTM
is a computer-aided non-diagnostic software tool designed to assist
radiologists in analyzing breast ultrasound images in order to reduce
unnecessary biopsies. The software allows the user to automatically or
manually segment (outline) and classify shape, texture and density of lesion in question.
The software allows the user to annotate, tag,
measure, and automatically save the processed lesions from practitioners' selected views
out of the breast ultrasound
test imaging sequence. Our tool automatically quantifies the segmented
lesion, calculates computer-base
BI-RADS®
score and then generates a report based on the image analysis process and the
radiologist input. The output may be viewed and sent to standard film or paper printers
or sent electronically to an Intranet's Local Area Networks or Internet Server. The software
may retrieve archived reports from a web server or other storage media.
If ordered by the client the report will contain
annotations by radiologist based on
BI-RADS® Breast Imaging reporting lexicon. In addition, the radiologist compiled report form has been
designed to support compliance with the
BI-RADS®
Ultrasound Lexicon
Classification Form.
When interpreted by a professional
practitioner, Companion SuiteTM or its Internet
version, computerized CAD scoring results may be useful in boosting the
practitioner's confidence in determining his/her biopsy threshold. Patient
management decisions should not be made based on the results of computerized
scoring and always delegate interpretation and diagnostic decisions to
professional practitioners. The ultrasound template images produced by Companion
SuiteTM should not be used by themselves for diagnostic purposes.
Please note that American College of Radiology
provides the following Disclaimers and Warranties regarding use of their
BI-RADS®
Atlas and Lexicon:
ACR Disclaimer:
"The American College of Radiology (ACR) Breast Imaging Reporting and Data
System Atlas (BI-RADS® Atlas) is the product of a collaborative
effort among members of various committees of the American College of Radiology
with cooperation from the National Cancer Institute, the Centers for Disease
Control and Prevention, the Food and Drug Administration, the American Medical
Association, the American College of Surgeons, and the College of American
Pathologists. Development of the ACR BI-RADS® – Ultrasound and ACR
BI-RADS® – MRI were supported in part by the United States Public
Health Service Office of Women's Health, Susan G. Komen Foundation, United
States Army Breast Cancer Research Program and the National Cancer Institute.
All referring physicians and radiologists should be aware of the benefits and
limitations of the application of imaging techniques. Imaging techniques
classified as investigational by the FDA have not been considered in developing
the BI-RADS® Atlas; however, study of new equipment and applications
should be encouraged. The ultimate decision regarding breast imaging procedures
and treatment must be made by the referring physician and radiologist in light
of all the circumstances presented in an individual examination."
ACR Warranty:
"Warranty limitations. (i) ACR BI-RADS® is provided on an "as is" basis, without
warranties of any kind, either express or implied, including, but not limited
to, warranties of title, or implied warranties of merchantability or fitness for
a particular purpose; (ii) the use of ACR BI-RADS® is at your own risk; (iii)
access to ACR BI-RADS® may be interrupted and may not be error free; (iv)
neither the American College of Radiology nor anyone else involved in creating,
producing, or delivering ACR BI-RADS® contained therein, shall be liable for any
direct or indirect, incidental, special, consequential, or punitive damages
arising out of your use or inability to use ACR BI-RADS®."